MetaCap

Precision Optics (POCI) vs Valion Bio (VBIO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Precision Optics is the larger company by market cap ($49.6 million vs $1.9 million), about 25.5 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

POCI versus VBIO key metrics
MetricPOCIVBIO
Share price$4.52$2.19
Market cap$49.60M$1.94M
1-day change+0.44%-7.98%
YTD return+7.88%—
1-year return+7.62%—
5-year return-31.52%—
Forward P/E150.67—
EPS (TTM)$-0.43$-161.21
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$6.15$78.75
52-week low$3.55$2.05
Distance from 52-week high-26.50%-97.22%
Average volume52.21K1.46M
Shares outstanding10.97M887.59K
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Precision Optics is about 25.5 times larger than Valion Bio by market value ($49.60M vs $1.94M).

POCI vs VBIO FAQ

Which is bigger, Precision Optics or Valion Bio?

Precision Optics (POCI) is larger, with a market capitalization of $49.60M compared with $1.94M for Valion Bio (VBIO).

Are Precision Optics and Valion Bio in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons